PGLX_ECOHS
ID PGLX_ECOHS Reviewed; 1205 AA.
AC P0DUF9; A0A7M3S2P4;
DT 02-JUN-2021, integrated into UniProtKB/Swiss-Prot.
DT 02-JUN-2021, sequence version 1.
DT 03-AUG-2022, entry version 5.
DE RecName: Full=Adenine-specific methyltransferase BrxX {ECO:0000303|PubMed:30418590};
DE EC=2.1.1.72 {ECO:0000269|PubMed:30418590};
DE AltName: Full=BREX protein PglX {ECO:0000305};
GN Name=pglX; Synonyms=brxX {ECO:0000303|PubMed:30418590};
GN OrderedLocusNames=EcHS_A0339;
OS Escherichia coli O9:H4 (strain HS).
OC Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC Enterobacteriaceae; Escherichia.
OX NCBI_TaxID=331112;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=HS;
RX PubMed=18676672; DOI=10.1128/jb.00619-08;
RA Rasko D.A., Rosovitz M.J., Myers G.S.A., Mongodin E.F., Fricke W.F.,
RA Gajer P., Crabtree J., Sebaihia M., Thomson N.R., Chaudhuri R.,
RA Henderson I.R., Sperandio V., Ravel J.;
RT "The pangenome structure of Escherichia coli: comparative genomic analysis
RT of E. coli commensal and pathogenic isolates.";
RL J. Bacteriol. 190:6881-6893(2008).
RN [2]
RP FUNCTION IN ANTIVIRAL DEFENSE, FUNCTION AS A DNA METHYLASE, INDUCTION, AND
RP DISRUPTION PHENOTYPE.
RC STRAIN=HS;
RX PubMed=30418590; DOI=10.1093/nar/gky1125;
RA Gordeeva J., Morozova N., Sierro N., Isaev A., Sinkunas T., Tsvetkova K.,
RA Matlashov M., Truncaite L., Morgan R.D., Ivanov N.V., Siksnys V., Zeng L.,
RA Severinov K.;
RT "BREX system of Escherichia coli distinguishes self from non-self by
RT methylation of a specific DNA site.";
RL Nucleic Acids Res. 47:253-265(2019).
RN [3]
RP FUNCTION IN ANTIVIRAL DEFENSE, ACTIVITY REGULATION, SUBUNIT, AND
RP INTERACTION WITH PHAGE T7 OCR.
RC STRAIN=HS;
RX PubMed=32515786; DOI=10.1093/nar/gkaa510;
RA Isaev A., Drobiazko A., Sierro N., Gordeeva J., Yosef I., Qimron U.,
RA Ivanov N.V., Severinov K.;
RT "Phage T7 DNA mimic protein Ocr is a potent inhibitor of BREX defence.";
RL Nucleic Acids Res. 48:7601-7602(2020).
CC -!- FUNCTION: BREX systems (bacteriophage exclusion) provide immunity
CC against bacteriophage. Part of a type 1 BREX system which protects
CC against dsDNA phage. This system allows phage adsorption but prevents
CC phage DNA replication, without degradation of the phage DNA.
CC Methylation of bacterial DNA by this protein guides self/non-self
CC discrimination. When the brxA-brxB-brxC-pglX-pglZ-brxL genes are
CC transformed into a susceptible E.coli strain (BW25113) they confer very
CC high resistance to infection by bacteriophage VR7 and VpaE1, about 100-
CC fold protection against lambda, T5 and T7 (probably with a mutated 0.3
CC gene) and no protection against RNA phage Qbeta, ssDNA phage M13 or
CC dSDNA phage T4 and VR5. Glycosylated phage DNA is not susceptible to
CC BREX. The BREX system does not confer resistance to lysogenic lambda
CC phage, i.e. prophage that are integrated into the chromosomal DNA and
CC then induced to form phage. {ECO:0000269|PubMed:30418590,
CC ECO:0000269|PubMed:32515786}.
CC -!- FUNCTION: Methylates the adenine in the fifth position of the hexamer
CC 5'-GGTAAG-3' in genomic DNA; methylates the same sequence in the few
CC phage that escape the BREX system. Methylated phage are now resistant
CC to BREX, showing immunity is provided by an epigenetic modification.
CC Expression of this protein alone has no effect on phage infection, does
CC not lead to methylated DNA and mildly inhibits growth.
CC {ECO:0000269|PubMed:30418590}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=a 2'-deoxyadenosine in DNA + S-adenosyl-L-methionine = an
CC N(6)-methyl-2'-deoxyadenosine in DNA + H(+) + S-adenosyl-L-
CC homocysteine; Xref=Rhea:RHEA:15197, Rhea:RHEA-COMP:12418, Rhea:RHEA-
CC COMP:12419, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789,
CC ChEBI:CHEBI:90615, ChEBI:CHEBI:90616; EC=2.1.1.72;
CC Evidence={ECO:0000269|PubMed:30418590};
CC -!- ACTIVITY REGULATION: Methyltransferase activity is partially inhibited
CC (20% reduction) by phage T7 protein OCR (AC P03775, gene 0.3).
CC Viability of cells overexpressing OCR is unaffected.
CC {ECO:0000269|PubMed:32515786}.
CC -!- SUBUNIT: Interacts with phage T7 protein Ocr (AC P03775, gene 0.3)
CC during an infection and when the protein is expressed from a plasmid.
CC {ECO:0000269|PubMed:32515786}.
CC -!- INDUCTION: Transcribed at slowly increasing levels as cells progress
CC from lag to exponential to stationary phase.
CC {ECO:0000269|PubMed:30418590}.
CC -!- DISRUPTION PHENOTYPE: No methylation of 5'-GGTAAG-3' in chromosomal
CC DNA, BREX no longer confers phage resistance.
CC {ECO:0000269|PubMed:30418590}.
CC -!- SIMILARITY: Belongs to the methyltransferase superfamily. PglX adenine
CC methyltransferase family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; CP000802; ABV04727.1; -; Genomic_DNA.
DR RefSeq; WP_001095585.1; NC_009800.1.
DR AlphaFoldDB; P0DUF9; -.
DR KEGG; ecx:EcHS_A0339; -.
DR OMA; RIIAIRF; -.
DR Proteomes; UP000001123; Chromosome.
DR GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR GO; GO:0008170; F:N-methyltransferase activity; IEA:InterPro.
DR GO; GO:0009007; F:site-specific DNA-methyltransferase (adenine-specific) activity; IEA:UniProtKB-EC.
DR GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR Gene3D; 3.40.50.150; -; 1.
DR InterPro; IPR003356; DNA_methylase_A-5.
DR InterPro; IPR002052; DNA_methylase_N6_adenine_CS.
DR InterPro; IPR029063; SAM-dependent_MTases_sf.
DR Pfam; PF02384; N6_Mtase; 1.
DR SUPFAM; SSF53335; SSF53335; 1.
DR PROSITE; PS00092; N6_MTASE; 1.
DR PROSITE; PS00589; PTS_HPR_SER; 1.
PE 1: Evidence at protein level;
KW Antiviral defense; Methyltransferase; S-adenosyl-L-methionine; Transferase.
FT CHAIN 1..1205
FT /note="Adenine-specific methyltransferase BrxX"
FT /id="PRO_0000452163"
SQ SEQUENCE 1205 AA; 137965 MW; 22E426D20634029C CRC64;
MNTNNIKKYA PQARNDFRDA VIQKLTTLGI AADKKGNLQI AEAETIGETV RYGQFDYPLS
TLPRRERLVK RAREQGFEVL VEHCAYTWFN RLCAIRYMEL HGYLDHGFRM LSHPETPTAF
EVLDHVPEVA EALLPESKAQ LVEMKLSGNQ DEALYRELLL GQCHALHHAM PFLFEAVDDE
AELLLPDNLT RTDSILRGLV DDIPEEDWEQ VEVIGWLYQF YISEKKDAVI GKVVKSEDIP
AATQLFTPNW IVQYLVQNSV GRQWLQTYPD SPLKDKMEYY IEPAEQTPEV QAQLAAITPA
SIEPESIKVL DPACGSGHIL TEAYNVLKAI YEERGYRTRD IPQLILENNI FGLDIDDRAA
QLSGFAMLML ARQDDRRILG RGVRLNIVSL QESKLDIAEV WTKLNFHQHM QRGSMGDMFT
QGTALANTDS AEYKLLMRTL ALFTSAKTLG SLIQVPQEDE AALKAFLERL YRLAVEGDIQ
QKEAAAELIP YIQQAWILAQ RYDAVVANPP YMGGKGMNGD LKEFAKKQFP DSKSDLFAMF
MQHAFSLLKE NGFNAQVNMQ SWMFLSSYEA LRGWLLDNKT FITMAHLGAR AFGQISGEVV
QTTAWVIKNN HSGFYKPVFF RLVDDNEEHK KNNLLNRMNC FKNTLQNDFK KIPGSPIAYW
ATLAFINSFL KLPALGTRAV KGLDTNGSID VFLRRWPEVS INSFDALGKG NSKWFPIAKG
GELRKWFGNH EYIINYENDG IELRKNKANL RNKDMYFQEG GTWTVVSTTG FSMRYMPKGF
LFDQGGSAVF CENNDELSIY NILACMNSKY INYSASLICP TLNFTTGDVR KFPVIKNNHL
EDLAKKAIEI SKADWNQFET SWEFSKNKLI EHKGNVAYSY ASYCNFQDKL YEQLVNIEKN
INNIIEEILG FKIETTENSE LITLNSNKIY RYGQSETNDT FLNRHRSDTI SELISYSVGC
QMGRYSLDRE GLVYAHEGNK GFAELAAEGA YKTFPADNDG ILPLMDDEWF EDDVTSRVKE
FVRTVWGEEH LQENLEFIAE SLCLYAIKPK KGESALETIR RYLSTQFWKD HMKMYKKRPI
YWLFSSGKEK AFECLVYLHR YNDATLSRMR TEYVVPLLAR YQANIDRLND QLDEASGGEA
TRLKRERDSL IKKFSELRSY DDRLRHYADM RISIDLDDGV KVNYGKFGDL LADVKAITGN
APEAI